QT Imaging Holdings (QTI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Revenue reached $6.5 million in Q1 2026, up 133% year-over-year, driven by shipment of 13 Breast Acoustic CT scanners and increased sales.
Achieved key regulatory milestones, including FDA 510(k) clearance for enhanced imaging, UAE clearance, and a new Category III CPT code effective January 2027.
Net loss narrowed to $3.4 million from $11.1 million in Q1 2025, reflecting higher sales and lower non-cash expenses.
Uplisted to Nasdaq in January 2026, enhancing market visibility and access to capital.
Strengthened clinical evidence and advisory team, including new senior clinical and medical advisors and studies showing strong concordance with MRI.
Financial highlights
Q1 2026 revenue was $6.5 million, up from $2.8 million in Q1 2025, primarily due to increased scanner shipments.
Gross margin for Q1 2026 was 41%, down from 65% in Q1 2025 due to product mix and higher cost of revenue.
Net loss for Q1 2026 was $3.4 million ($0.25/share), a significant improvement from $11.1 million ($1.21/share) in Q1 2025.
Operating expenses rose to $5.0 million from $2.9 million year-over-year, mainly due to higher R&D, SG&A, and compensation costs.
Cash, restricted cash, and equivalents totaled $7.0 million as of March 31, 2026.
Outlook and guidance
2026 revenue guidance reaffirmed at approximately $39 million, more than double 2025 revenue, based on contracted scanner shipments and early monetization of cloud-based services.
Distribution agreements in place for over $75 million in contracted scanner sales through 2028, including minimum order quantities in the U.S. and Gulf region.
Management expects continued losses and negative cash flows until sufficient revenue is achieved.
Current liquidity, credit facilities, and expected revenue from distribution agreements are believed sufficient for at least the next 12 months.
Geopolitical risks in the Middle East may impact ability to ship scanners and recognize revenue in the region.
Latest events from QT Imaging Holdings
- All proposals, including director elections and equity plan amendment, passed by wide margins.QTI
AGM 202630 Jul 2026 - Shareholders will vote on director elections, auditor ratification, and an expanded equity incentive plan.QTI
Proxy filing2 Jul 2026 - Annual meeting to vote on directors, auditor, and equity plan amid strong growth and governance.QTI
Proxy filing22 Jun 2026 - Q3 2025 revenue rose 339% to $4.2M; 2026 revenue outlook raised to $39M.QTI
Q3 202515 May 2026 - FDA-cleared 3D breast imaging platform drives rapid growth with AI and global partnerships.QTI
Investor presentation13 May 2026 - $2.56M PIPE financing and $1.0M Q3 revenue support liquidity amid ongoing commercialization.QTI
Q3 202422 Apr 2026 - Q2 2024 revenue hit $1.7M with 51% margin; net loss widened to $6.4M amid higher costs.QTI
Q2 202422 Apr 2026 - Q1 2025 revenue doubled to $2.8M with 65% margin; net loss widened to $11.1M.QTI
Q1 202522 Apr 2026 - Q2 revenue doubled to $3.7M, net loss widened, liquidity boosted by new financings.QTI
Q2 202522 Apr 2026